🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Clinical Study on Using TCR to Predict the Effect of Tislelizumab + Chemotherapy in the First-line Treatment of ES-SCLC
NCT07244016Extensive-stage Small-cell Lung Cancer
Henan Cancer Hospital
Observational
40
Zhengzhou
2025-02-20
Not yet open
CMTS4520-Assisted Washed Microbiota Transplantation for Chronic Constipation in Adults
NCT06832176Constipation
The Second Hospital of Nanjing Medical University
Phase 1/2
100
Nanjing
2025-02-20
Recruiting
CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)
NCT06822881Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc)
Beijing GoBroad Hospital
Phase 1
27
Beijing
2025-02-20
Not yet open
Impact of Thyroid Treatment on Ovarian Function and Pregnancy Outcomes in Women with Differentiated Thyroid Cancer
NCT06845098Thyroid Gland
Zhejiang Provincial People's Hospital
Not applicable
300
Hangzhou
2025-02-20
Active, closed
CMTS4520 for Chronic Diarrhoea in Adults
NCT06839586Diarrhoea
The Second Hospital of Nanjing Medical University
Phase 1/2
100
Nanjing
2025-02-20
Active, closed
Evaluation of TQB3616 Capsules in a Phase II Clinical Trial for Recurrent/Metastatic Breast Cancer
NCT06702618Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
33
Bengbu, Jiangmen, Xingtai, Harbin, Luohe, Changsha, Nanjing, Nantong
2025-02-20
Not yet open
CMTS0929 for Inflammatory Bowel Disease
NCT06844708Inflammatory Bowel Disease (IBD)
The Second Hospital of Nanjing Medical University
Phase EARLY_PHASE1
12
Nanjing
2025-02-20
Recruiting
A Study Evaluating the Effect of Aumolertinib on the Pharmacokinetics of Midazolam in Patients With NSCLC
NCT06926413Non Small Cell Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
20
Hangzhou
2025-02-20
Recruiting
Exploratory Clinical Study on the Safety and Efficacy of Targeted BCMA Autologous CART Cell Injection in Subjects With Recurrent/Refractory Light Chain Amyloidosis
NCT06983951Light Chain Amyloidosis
Beijing Boren Hospital
Not applicable
30
Beijing
2025-02-20
Recruiting
Camrelizumab Combined With Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC) as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma(HCC)
NCT06796803Potentially Resectable Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
Phase 2/3
398
Harbin, Shanghai
2025-02-20
Recruiting
Exploring the Value of Urine Proteomics-based Dynamic Surveillance for Early Recurrence After Radical Surgery for Hepatocellular Carcinoma: a Prospective Cohort Study
NCT06861114Hepatocellular Carcinoma (HCC)
Zhujiang Hospital
Observational
38
Guangzhou
2025-02-20
Recruiting
Coronary Aspiration Catheter Clinical Trial
NCT06951724ST-segment Elevation Myocardial Infarction (STEMI)
BrosMed Medical Co., Ltd
Not applicable
144
Shanghai
2025-02-20
Not yet open
Optimal LDL-C Target in High-risk Patients After PCI
NCT06821711Chronic Coronary Syndrome, Acute Coronary Syndromes, Percutaneous Coronary Intervention, High Risk Patient
Xijing Hospital
Not applicable
12,000
Xi'an
2025-02-20
Recruiting
Autologous CD19CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases
NCT06993493Autoimmune Disease
Beijing Boren Hospital
Not applicable
12
Beijing
2025-02-20
Not yet open
Comparison of Physiological Effects of Two Types of High-Flow Oxygen Therapy in Tracheostomized Patients
NCT06816745Critical Care, Oxygen Therapy, Tracheostomy
Jian-Xin Zhou
Not applicable
20
Beijing
2025-02-20
Recruiting
Safety and Efficacy of CD19 CAR-T Therapy for Recurrent/Refractory Autoimmune Diseases
NCT06983964Autoimmune Disease
Beijing Boren Hospital
Not applicable
12
Beijing
2025-02-20
Recruiting
A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors
NCT06769152Cervical Cancer, Ovarian Cancer
Shanghai Henlius Biotech
Phase 2
190
Ji'nan
2025-02-20
By invitation
PRIor Myocardial Infarction Identification on Electrocardiogram
NCT06811194Prior Myocardial Infarction
The Third People's Hospital of Chengdu
Observational
12,000
Chengdu
2025-02-20
Not yet open
CMTS0929 for Clostridioides Difficile Infection
NCT06836427Clostridioides Difficile Infection
The Second Hospital of Nanjing Medical University
Phase EARLY_PHASE1
12
Nanjing
2025-02-20
Not yet open
CMTS4520-Assisted Washed Microbiota Transplantation for Chronic Diarrhoea in Adults
NCT06839599Diarrhea
The Second Hospital of Nanjing Medical University
Phase 1/2
100
Nanjing
2025-02-20
Recruiting
Modified Tumor-free Techniques Operation to Cervical Cancer
NCT06836869Cervical Cancer Stage IB2
Peking Union Medical College Hospital
Not applicable
524
Lanzhou, Guangzhou, Cangzhou, Shijiazhuang, Changsha, Changchun, Shanghai, Xianyang
2025-02-20
Not yet open
Observation on Administration of Propofol at Different Titration Endpoints
NCT06685198Anesthesia, General, Hemodynamics
SanQing Jin
Not applicable
258
Guangzhou
2025-02-20
Recruiting
Clinical Efficacy and Safety Assessment of Breast-Conserving Surgery for Central Breast Cancer: A Prospective Randomized Controlled Trial
NCT06938360Breast Cancer
Xijing Hospital
Not applicable
158
Xi'an
2025-02-20
Recruiting
The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer
NCT05798845NSCLC
Shanghai Chest Hospital
Phase 2
124
Shanghai
2025-02-20
Recruiting
Research on the Application of CARE Combined With AIDET Nurse-Patient Communication Model in Implementing Service Remediation in Outpatient Clinics
NCT06967350Communication, Service Recovery
Bao Yan
Not applicable
75
Yiwu
2025-02-19
Recruiting
Balloon Angioplasty for Minor Unstable Stroke With IntraCranial Atherosclerosis Stenosis (BAMUS-ICAS)
NCT06763458Ischemic Stroke
General Hospital of Shenyang Military Region
Not applicable
100
Shenyang
2025-02-19
Recruiting
NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis
NCT06676631Refractory Systemic Lupus Erythematosus, Refractory Lupus Nephritis
Guangdong Provincial People's Hospital
Phase 1
18
Guangzhou
2025-02-19
Recruiting
FDG PET/MRI Imaging of Patellofemoral Joint Osteoarthritis
NCT07625150Patellofemoral Osteoarthritis, Knee Osteoarthritis, Knee Pain, Inflamation
University of California, San Francisco
Observational
50
2025-02-19
Recruiting
Safety and Efficacy Evaluation of Sodium Hyaluronate 32mg/ml in Improving Facial Skin Dryness and Dullness
NCT06914583Facial Dryness, Facial Dullness
IBSA Farmaceutici Italia Srl
Not applicable
500
Beijing, Changde, Chengdu, Shanghai, Xi'an
2025-02-19
Recruiting
ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC
NCT07157969HCC - Hepatocellular Carcinoma
Peking Union Medical College Hospital
Phase 2
300
Beijing
2025-02-19
Not yet open
Efficacy and Safety of AL-001 Ophthalmic Injection in Subjects with WAMD
NCT06839339Wet Age-related Macular Degeneration (wAMD)
Beijing Anlong Biopharmaceutical Co., Ltd.
Phase 2
40
Beijing
2025-02-18
Recruiting
A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors
NCT06703177Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2
876
Guangzhou
2025-02-18
Active, closed
Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01
NCT06727565Head and Neck Squamous Cell Carcinoma
Gilead Sciences
Phase 2
39
Chengdu, Hangzhou, Nanning, Shanghai, Wuhan
2025-02-18
Recruiting
JSKN003 Versus Trastuzumab Emtansine (T-DM1) for HER2-Positive, Advanced Breast Cancer
NCT06846437Unrespectable Locally Advanced and or Metastatic HER2 Positive Breast Cancer Participants
Shanghai JMT-Bio Inc.
Phase 3
228
Shanghai
2025-02-18
Recruiting
Nomogram for Astigmatism Correction of KLEx
NCT07605221Astigmatism
Tianjin Eye Hospital
Not applicable
100
Tianjin
2025-02-18
Recruiting
Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC
NCT06864624NSCLC
Tang-Du Hospital
Phase 2
27
Changsha, Yinchuan, Xi'an
2025-02-18
Active, closed
KRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors
NCT06767046Colorectal, Pancreatic, Non-small Cell Lung Cancer (NSCLC)
Corregene Biotechnology Co., Ltd
Phase 1
8
Beijing
2025-02-18
Not yet open
Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCLC
NCT06837948Locally Advanced Non-Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
160
Shanghai
2025-02-18
Active, closed
A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Type 2 Diabetes Mellitus Subjects (T2DM) Treated With Basal + Prandial Insulin
NCT06767761Diabetes
Gan & Lee Pharmaceuticals.
Phase 3
580
Changsha
2025-02-18
Recruiting
Effect of Low Valine Diet on Body Weight and Metabolic Parameters
NCT06883578Overweight/obesity, Metabolic Associated Fatty Liver Disease, Metabolic Diseases
Shanghai Zhongshan Hospital
Not applicable
48
Shanghai
2025-02-18
Recruiting
Echocardiography Guided TAVR (Echo TAVR)
NCT07030062Transcatheter Aortic Valve Replacemen, Echocardiography
Pan Xiangbin
Observational
20
Beijing
2025-02-18
Recruiting
The Characteristics of Oral Microbiota in Chronic Pancreatitis and Autoimmune Pancreatitis
NCT07015580Oral Microbiota, Pancreatitis, Pancreatic Cancer
Ruijin Hospital
Observational
360
Shanghai
2025-02-18
Recruiting
A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC
NCT06754930Non-small Cell Lung Cancer (NSCLC)
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2
400
Shanghai
2025-02-18
Recruiting
Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis
NCT06696417Moderate to Severe Plaque Psoriasis
First Hospital of China Medical University
Observational
1,516
Shenyang
2025-02-17
Active, closed
A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Diabetes Mellitus (T2DM)
NCT06767735Diabetes
Gan & Lee Pharmaceuticals.
Phase 3
580
Linyi
2025-02-17
Not yet open
Application of 18F-CP6A PET Imaging in Synucleinopathies
NCT06827821Synucleinopathies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
18
Wuhan
2025-02-17
Active, closed
Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT06712888Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University
Phase 3
466
Fuzhou, Guangzhou, Shenzhen, Zhanjiang, Nanning, Guiyang, Changsha, Chengdu
2025-02-17
Recruiting
POLA-R-CHP in the First-line Treatment of Transformed DLBCL
NCT06743945Transformed Lymphoma
Fudan University
Phase 2
20
Shanghai
2025-02-17
Recruiting
Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer
NCT06686030Platinum-sensitive Ovarian Cancer
Akeso
Phase 2
150
Wuhan
2025-02-17
Recruiting
Head-to-head Study of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID vs. Vonoprazan 20 mg BID Plus Amoxicillin 1 g TID for H. Pylori Eradication
NCT07242456Helicobacter Pylori Infection
First People's Hospital of Hangzhou
Phase 2/3
240
Hangzhou
2025-02-17
Recruiting
RAPART in Locally Advanced Non-small Cell Lung Cancer Patients
NCT07164885Locally Advanced Non-small Cell Lung Cancer
Capital Medical University
Not applicable
911
Shenzhen
2025-02-17
Recruiting
IN10018 With Nab-Paclitaxel and Cadonilimab for Metastatic or Recurrent Gastric-Type Cervical Adenocarcinoma: Phase 2 Trial
NCT06654011Cervical Adenocarcinoma, Gastric-type Endocervical Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2
25
Wuhan, Xiangyang
2025-02-17
Recruiting
Phase I Clinical Study to Evaluate the Safety and Efficacy of RGB-5088 in Patients With Type 1 Diabetes Mellitus
NCT06731218Diabetes Mellitus, Type 1, Diabetes Mellitus
Hangzhou Reprogenix Bioscience, Inc
Phase 1
10
Tianjin
2025-02-17
Recruiting
Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients
NCT06696794Non-Muscle-Invasive Bladder Cancer (NMIBC)
Shaogang Wang
Phase 3
180
Wuhan, Xiangyang
2025-02-17
Recruiting
Neoadjuvant Nivolumab Plus Ipilimumab in Resectable NSCLC (GALAXY 3)
NCT06926790Lung Cancer - Non Small Cell
The First Affiliated Hospital of Guangzhou Medical University
Phase 2
69
Guangzhou
2025-02-17
Not yet open
ExCR's Effects and Safety in Vulnerable ADHF Patients
NCT06795737Acute Decompensated Heart Failure (ADHF)
YE Jing
Not applicable
88
Beijing
2025-02-17
Active, closed
Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Chinese Population Aged 40 Years and Older
NCT06851832Herpes Zoster, Herpes Zoster Vaccine
Ab&B Bio-tech Co., Ltd.JS
Phase 1/2
960
Xuchang
2025-02-16
Recruiting
Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer
NCT06861192Prostate CA
baotai Liang
Phase 2/3
83
Nanjing
2025-02-16
Recruiting
Effect of Remote Local Peripheral Nerve Cooling on Pain of Arterial Puncture
NCT06838572Acute Pain
The Second Affiliated Hospital of Chongqing Medical University
Not applicable
100
Chongqing
2025-02-15
Not yet open
A Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Hormone Receptor Positive Breast Cancer Patients
NCT06825949Breast Cancers
Guangdong Provincial People's Hospital
Not applicable
55
Guangzhou
2025-02-15
Recruiting
TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALL
NCT06481735Acute Lymphocytic Leukemia
Chinese PLA General Hospital
Phase 1/2
30
Beijing, Changzhi, Tianjin
2025-02-15
Recruiting
A Clinical Study Evaluating the Efficacy of Systemic Chemotherapy and Immune Checkpoint Inhibitors Combined With Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer Patients With Peritoneal Metastasis
NCT06685887Gastric Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2
34
Wuhan
2025-02-15
Recruiting
BiodEgradable Soaked Amiodarone paTch Use for the Prevention of Atrial Fibrillation After Cardiac Surgery
NCT06722196Atrial Fibrillation (AF)
Jilin Heart Hospital
Phase 3
500
Changchun
2025-02-15
Recruiting
Comparing FET Guided by ERA Vs Standard Timing in Patients with Recurrent Implantation Failure
NCT06762626Recurrent Implantation Failure, Infertility
The University of Hong Kong
Not applicable
734
Hong Kong
2025-02-15
Recruiting
Clinical Study of Acupuncture Treatment of Knee Osteoarthritis
NCT06805188Osteoarthritis of the Knees, Osteoarthritis (OA) of the Knee, Osteoarthritis
Wu zenan
Not applicable
350
Nanchang
2025-02-15
Not yet open
An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis
NCT06759948Generalized Myasthenia Gravis (gMG)
Chongbo Zhao
Phase 1
18
Shanghai
2025-02-15
Not yet open
Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Triple-negative Breast Cancer
NCT06798506TNBC - Triple-Negative Breast Cancer
Fudan University
Observational
300
Shanghai
2025-02-15
Recruiting
Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whole Slide Imaging and MRI
NCT06831357Nasopharyngeal Cancinoma (NPC), Distant Metastasis
Sun Yat-sen University
Observational
500
Guangzhou
2025-02-15
Not yet open
Gene Therapy for Neurofibromatosis Type 2 (NF2) with ST002
NCT06834438NF2 Deficiency
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
9
Beijing
2025-02-15
Recruiting
The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer
NCT06738160NSCLC, Stereotactic Body Radiation Therapy (SBRT), Immunotherapy
Fudan University
Phase 2
27
Shanghai
2025-02-15
Not yet open
Heterogeneity of 68Ga-FAPI Uptake As Imaging Biomarker in T-DXd Treatment for Brain Metastasis of HER2 Positive Breast Cancer
NCT06797622Breast Cancer, Metastatic Breast Cancer
Fudan University
Phase 2
50
Shanghai
2025-02-15
Not yet open
Study of Tretinoin Capsules in Combination With Azacitidine and Venetoclax in Treatment Naïve Participants With Acute Myeloid Leukemia
NCT06841952AML, Adult
The First Affiliated Hospital of Soochow University
Not applicable
158
Suzhou
2025-02-15
Not yet open
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Herpes Zoster Vaccine
NCT06801509Herpes Zoster
Sinocelltech Ltd.
Phase 1/2
540
Dazhou
2025-02-15
Active, closed
A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin
NCT06767748Diabetes
Gan & Lee Pharmaceuticals.
Phase 3
620
Linyi
2025-02-15
Not yet open
QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC
NCT06750861Pancreatic Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
30
Beijing
2025-02-15
Not yet open
Pulsed Field Ablation Versus Radiofrequency Ablation for Persistent Atrial Fibrillation
NCT06791629Persistent Atrial Fibrillation, Radiofrequency Catheter Ablation, Pulsed Field Ablation
Beijing Anzhen Hospital
Not applicable
700
Beijing
2025-02-15
Active, closed
Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET).
NCT06921395Female Infertility
LG Chem
Phase 4
248
Zhengzhou
2025-02-15
Not yet open
Therapeutic Effect of Bifidobacterium Longum in Patients with Acute Pancreatitis: a Randomized, Double-Blind, Placebo-Controlled Trial
NCT06639516Acute Pancreatitis
The First Affiliated Hospital of Nanchang University
Not applicable
60
Nanchang
2025-02-15
Recruiting
A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria
NCT06819826IgA Nephropathy (IgAN)
Biocity Biopharmaceutics Co., Ltd.
Phase 3
360
Guangzhou
2025-02-14
Recruiting
Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCL
NCT06832267Primary Central Nervous System Lymphoma
Zhejiang Cancer Hospital
Not applicable
44
Hangzhou
2025-02-14
Recruiting
Nanobody-Based Anti-CD5 CAR-T for Relapsed/Refractory T-ALL/NHL
NCT06874946Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, T - Cell Lymphoma, PTCL
Peking University People's Hospital
Phase 1/2
30
Beijing
2025-02-14
Recruiting
The Safety and Efficacy of Umbilical Cord Blood Mononuclear Cells in Patients With Secondary Poor Graft Function After Hematopoietic Stem Cell Transplantation
NCT06792682Poor Graft Function
Institute of Hematology & Blood Diseases Hospital, China
Phase 1
15
Tianjin
2025-02-14
Recruiting
Efficacy and Safety of Cocktail of Ropivacaine for Local Infiltration Analgesia in Patients Undergoing Laparoscopic Cholecystectomy
NCT06819748Cholecystectomy, Laparoscopic, Ambulatory Surgical Procedures, Multimodal Analgesia
Sichuan Provincial People's Hospital
Not applicable
210
Chengdu
2025-02-14
Recruiting
Accurate Assessment and Intervention Research on Newborn Whole Genome Sequencing and Genetic Disease Risk
NCT07365254Genetic Disease
Women's Hospital School Of Medicine Zhejiang University
Observational
1,000,000
Hangzhou
2025-02-14
Recruiting
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
NCT06760819Advanced Solid Tumors, HER2 Mutation
Bayer
Phase 2
111
Beijing, Changsha, Shanghai, Hangzhou
2025-02-13
Active, closed
A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus
NCT06778967Type 2 Diabetes Mellitus (T2DM)
Gan & Lee Pharmaceuticals.
Phase 3
1,100
Tianjin
2025-02-13
Recruiting
Efficacy of Thermal Ablation Combined With Antithyroid Drugs in the Treatment of Primary Hyperthyroidism
NCT07557810Complication Rate, Efficacy and Safety, Hyperthyroidism/Thyrotoxicosis, Cure Rate
Chinese PLA General Hospital
Observational
454
Beijing
2025-02-13
Active, closed
A Trial of SHR0302Base in Patients With Vitiligo
NCT06790862Vitiligo
Jiangsu HengRui Medicine Co., Ltd.
Phase 2
155
Jinan
2025-02-13
By invitation
Multimodal Radiomics Model (18F-FAPI PET/CT + CMR) for AL Cardiac Amyloidosis Prognosis
NCT07103863AL Amyloidosis (AL), Cardiac Amyloidosis
Beijing Anzhen Hospital
Observational
49
Beijing
2025-02-13
Recruiting
A Phase I Trial of Tumor-Associated Lymph Node T-Cell Injection With Advanced Malignant Solid Tumors
NCT06716619Tumor Associated Lymph Node T Cell, Advanced Solid Tumor, Immunotherapy, Serplulimab Injection
Guangzhou FineImmune Biotechnology Co., LTD.
Phase 1
32
Guangzhou
2025-02-13
Recruiting
Autologous Decidual-like Natural Killer Cells Therapy for Infertility or Adverse Pregnancy History
NCT06821685Abortion, Habitual, Infertility Unexplained, Embryo Implantation, Pre-Eclampsia
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1
14
Nanjing
2025-02-13
Recruiting
A Study of CSCJC3456 in Patients With Advanced Malignant Tumors
NCT06717750Advanced Malignant Solid Tumors
Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.
Phase 1
102
Beijing, Shenyang
2025-02-13
Recruiting
Topical Diclofenac for Prevention of Radiation-induced Dermatitis
NCT06905561Head and Neck Tumor, Breast Cancer
The Second Affiliated Hospital of Hainan Medical University
Not applicable
156
Haikou
2025-02-13
By invitation
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)
NCT06908226Developmental and Epileptic Encephalopathy
Longboard Pharmaceuticals
Phase 3
324
Beijing, Guangzhou, Wuhan, Shanghai Shi
2025-02-12
Recruiting
Reverse HER2-negative Immune Resistant Breast Cancer
NCT06731140HER2 Negative Breast Cancer
Fudan University
Phase 2
10
Shanghai
2025-02-12
Recruiting
Effect of Low-dose EsketaMine on dElirium in High-risk Elderly Patients uNdergoing elecTive Surgery (ELEMENT)
NCT06817239Delirium in Old Age, Delirium, Postoperative, Anesthesia, Cognitive Dysfunction
Nanfang Hospital, Southern Medical University
Not applicable
1,670
Fuzhou, Guangzhou, Ganzhou
2025-02-12
Not yet open
A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Triple-Negative and HER2+ Breast Cancer Patients
NCT06825975Breast Cancers
Guangdong Provincial People's Hospital
Not applicable
348
Guangzhou
2025-02-12
Recruiting
A Study of BL-M08D1 in Patients With Locally Advanced or Metastatic Solid Tumors
NCT06718621Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1
22
Shanghai
2025-02-12
Recruiting
A Phase III Study of SHR-A2102 Versus Investigator-selected Therapy in Advanced Urothelial Carcinoma
NCT06738251Advanced Urothelial Carcinoma
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 3
402
Beijing
2025-02-12
Recruiting
Research on the Effect of Noise Cancelling Headphones in Reducing Postoperative Pain
NCT06918470Noise Cancelling Headphones, Postoperative Pain
Maternal and Child Health Hospital of Hubei Province
Not applicable
300
Wuhan
2025-02-12
Rows per page Showing 9401–9500 of 19052
Previous 93 94 95 96 97 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=95

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.